SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹0.58 Cr | ₹-0.09 Cr | ₹0.20 Cr | ₹0.24 Cr | ₹0.28 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHREE GANESH REMEDIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹0.58 Cr |
Mar2023 | ₹-0.09 Cr |
Mar2022 | ₹0.20 Cr |
Mar2021 | ₹0.24 Cr |
Mar2020 | ₹0.28 Cr |
How is Deferred Tax Assets / Liabilities of SHREE GANESH REMEDIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.58 Cr | Positive | |
Mar2023 | ₹-0.09 Cr | Negative | |
Mar2022 | ₹0.20 Cr | -16.32 | |
Mar2021 | ₹0.24 Cr | -13.09 | |
Mar2020 | ₹0.28 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹1,081.2 Cr | 27.6% | 24.6% | 6.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,228.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,023.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹119,474.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,599.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 27.6% |
24.6% |
6.7% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses